P 02 (Mercaptopurine 50 MG)
Pill imprint P 02 has been identified as Mercaptopurine 50 MG.
Mercaptopurine is used in the treatment of crohn's disease, maintenance; ulcerative colitis, maintenance; crohn's disease, acute; acute lymphoblastic leukemia; autoimmune hepatitis (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Mercaptopurine 50 MG is not a controlled substance under the Controlled Substance Act (CSA).
- P 02
- 50 MG
- 12.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|68084-0325||Amerisource Health Services|
|54868-5282||Physicians Total Care Inc (repackager)|
More about mercaptopurine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 16 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.